- Home
- CGON vs VSCO Comparison
CGON vs VSCO Comparison
Compare CGON & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- VSCO
- Stock Information
- Founded
- CGON 2010
- VSCO 1977
- Country
- CGON United States
- VSCO United States
- Employees
- CGON N/A
- VSCO N/A
- Industry
- CGON
- VSCO Clothing/Shoe/Accessory Stores
- Sector
- CGON
- VSCO Consumer Discretionary
- Exchange
- CGON NYSE
- VSCO Nasdaq
- Market Cap
- CGON 2.1B
- VSCO 1.9B
- IPO Year
- CGON 2024
- VSCO N/A
- Fundamental
- Price
- CGON $25.55
- VSCO $18.84
- Analyst Decision
- CGON Strong Buy
- VSCO Hold
- Analyst Count
- CGON 10
- VSCO 12
- Target Price
- CGON $64.44
- VSCO $26.50
- AVG Volume (30 Days)
- CGON 784.3K
- VSCO 4.0M
- Earning Date
- CGON 08-07-2025
- VSCO 06-11-2025
- Dividend Yield
- CGON N/A
- VSCO N/A
- EPS Growth
- CGON N/A
- VSCO 55.42
- EPS
- CGON N/A
- VSCO 2.07
- Revenue
- CGON $662,000.00
- VSCO $6,224,000,000.00
- Revenue This Year
- CGON N/A
- VSCO $2.23
- Revenue Next Year
- CGON $14,719.70
- VSCO $1.77
- P/E Ratio
- CGON N/A
- VSCO $9.07
- Revenue Growth
- CGON 224.51
- VSCO 1.47
- 52 Week Low
- CGON $14.80
- VSCO $13.76
- 52 Week High
- CGON $40.47
- VSCO $48.73
- Technical
- Relative Strength Index (RSI)
- CGON 48.31
- VSCO 41.35
- Support Level
- CGON $25.02
- VSCO $18.25
- Resistance Level
- CGON $26.97
- VSCO $23.33
- Average True Range (ATR)
- CGON 1.14
- VSCO 1.02
- MACD
- CGON -0.18
- VSCO -0.40
- Stochastic Oscillator
- CGON 17.79
- VSCO 15.76
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.